Brenda Raud

Brenda Raud

Postdoctoral fellow

+31 20 512 2067 John Haanen

I joined the group of John Haanen and the Amsterdam Biotherapeutics Unit (AmBTU) in April 2019 to research T cell immunology in human cancer and to contribute to the development and clinical application of novel cancer immunotherapies based on neoantigen-specific T cells.


This site uses cookies

This website uses cookies to ensure you get the best experience on our website.